ARCHIVES

CCOP Letters Of Intent Reach 232; Frelick Experts 80-90 Percent Of them To Qualify For Applications

This article is from The Cancer Letter archive.

Vol. 08 No. 34 | September 3, 1982

Download PDF Visit The Full Archive

Related Articles

Duke University Suspends Two Clinical Trials After Journal Paper Questions Assay Validity

October 9, 2009

Funding Opportunities. (8-page issue).

May 2, 2003

Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer

July 26, 2002

In Brief: ONS, ASCO AACR Meetings Open In St. Louis Next Week; Bristol-Myers Adds Farber, McArdle Grants

April 16, 1982

Clinical Trials Approved By NCI Last Month Are Listed

February 28, 2003

HHS, MB, OSTP Urge President To Veto Biomedical Research Authorization; Senate Pushes FTE Levels

October 25, 1985